tazarotene

Generic: tazarotene

Labeler: solaris pharma corporation
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tazarotene
Generic Name tazarotene
Labeler solaris pharma corporation
Dosage Form GEL
Routes
CUTANEOUS
Active Ingredients

tazarotene 1 mg/g

Manufacturer
Solaris Pharma Corporation

Identifiers & Regulatory

Product NDC 73473-310
Product ID 73473-310_d0c2fbdf-c1f1-43de-93ef-7da5e6279875
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213644
Listing Expiration 2026-12-31
Marketing Start 2025-01-03

Pharmacologic Class

Established (EPC)
retinoid [epc]
Chemical Structure
retinoids [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 73473310
Hyphenated Format 73473-310

Supplemental Identifiers

RxCUI
313199 313201
UNII
81BDR9Y8PS
NUI
N0000175607 M0018962

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tazarotene (source: ndc)
Generic Name tazarotene (source: ndc)
Application Number ANDA213644 (source: ndc)
Routes
CUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 1 mg/g
source: ndc
Packaging
  • 1 TUBE in 1 CARTON (73473-310-10) / 100 g in 1 TUBE
  • 1 TUBE in 1 CARTON (73473-310-30) / 30 g in 1 TUBE
source: ndc

Packages (2)

73473-310-10 1 TUBE in 1 CARTON (73473-310-10) / 100 g in 1 TUBE 73473-310-30 1 TUBE in 1 CARTON (73473-310-30) / 30 g in 1 TUBE

Ingredients (1)

tazarotene (1 mg/g)

Linked Drug Pages (1)

Tazarotene ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["CUTANEOUS"], "spl_id": "d0c2fbdf-c1f1-43de-93ef-7da5e6279875", "openfda": {"nui": ["N0000175607", "M0018962"], "unii": ["81BDR9Y8PS"], "rxcui": ["313199", "313201"], "spl_set_id": ["f1c98c4a-f101-4f3c-851a-39c827415c46"], "pharm_class_cs": ["Retinoids [CS]"], "pharm_class_epc": ["Retinoid [EPC]"], "manufacturer_name": ["Solaris Pharma Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (73473-310-10)  / 100 g in 1 TUBE", "package_ndc": "73473-310-10", "marketing_start_date": "20250103"}, {"sample": false, "description": "1 TUBE in 1 CARTON (73473-310-30)  / 30 g in 1 TUBE", "package_ndc": "73473-310-30", "marketing_start_date": "20250103"}], "brand_name": "Tazarotene", "product_id": "73473-310_d0c2fbdf-c1f1-43de-93ef-7da5e6279875", "dosage_form": "GEL", "pharm_class": ["Retinoid [EPC]", "Retinoids [CS]"], "product_ndc": "73473-310", "generic_name": "Tazarotene", "labeler_name": "Solaris Pharma Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tazarotene", "active_ingredients": [{"name": "TAZAROTENE", "strength": "1 mg/g"}], "application_number": "ANDA213644", "marketing_category": "ANDA", "marketing_start_date": "20250103", "listing_expiration_date": "20261231"}